As of 2026-01-03, the Intrinsic Value of Immunovant Inc (IMVT) is -13.25 USD. This IMVT valuation is based on the model Peter Lynch Fair Value. With the current market price of 25.91 USD, the upside of Immunovant Inc is -151.15%.
Based on its market price of 25.91 USD and our intrinsic valuation, Immunovant Inc (IMVT) is overvalued by 151.15%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -13.25 - -13.25 | -13.25 | -151.15% |
| P/E | (47.97) - (66.79) | (64.34) | -348.3% |
| DDM - Stable | (16.21) - (43.50) | (29.85) | -215.2% |
| DDM - Multi | (1.56) - (3.28) | (2.11) | -108.2% |
| Market Cap (mil) | 4,541.51 |
| Beta | 1.18 |
| Outstanding shares (mil) | 175.28 |
| Enterprise Value (mil) | 4,019.63 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.47% |
| Cost of Debt | 5.00% |
| WACC | 8.73% |